Lataa...
The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors
The past decade has witnessed an explosion in trial data on JAK inhibitors (JAKi). These small molecules target the Janus kinase - signal transducer and activator of transcription (JAK-STAT) pathway, blocking crucial cytokines across a septum of rheumatic diseases. As a class, JAKi are beginning to...
Tallennettuna:
| Julkaisussa: | Pharmacol Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6876279/ https://ncbi.nlm.nih.gov/pubmed/31401212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2019.104392 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|